Andy G. Chen

Andy G. Chen, PhD CFA, currently serves as Senior VP and Analyst in Equity Research at Wolfe Research, LLC, focusing on the biotech sector. Previously, Andy worked in equity research at Berenberg Capital Markets and held roles in investments at Roivant Sciences, where key contributions included a major deal with Pfizer and the formation of Priovant Therapeutics. Prior experience also includes sell-side research at AB Bernstein, where Andy was part of a top-ranked team covering significant biotech and pharmaceutical companies, as well as management consulting at The Dedham Group, leading projects in commercial strategy for large pharmaceutical clients. Andy G. Chen earned a PhD in Molecular Biology from Yale University and a BA in Genetics and Development from Cornell University.